OVERVIEW
Vaccine Industry: COVID-19 vaccines, oral inactivated polio vaccine, lyophilized attenuated hepatitis A vaccine, etc.
Cell and Gene Therapy: Viral vector systems including adenovirus, adeno-associated virus, and lentivirus; harvesting high-purity, high-titer viral particles from cell lines such as VERO, MDCK, and HEK293.
Stem Cell Field: Process scale-up for hematopoietic progenitor cells (HPC), mesenchymal progenitor cells (haMPC), lung stem cells, and other mesenchymal stem cells and pluripotent stem cells.
FEATURES
1.Available in 1, 2, 5, 10, and 40 layers, allowing for convenient and scalable culture expansion.
2.ADsurface surface treatment enhances cell adhesion and uniformity, making it an ideal choice for adherent cell culture.
3.Mature manufacturing process ensures no welding particles are produced.
4.Can be expanded to up to 40 layers and is compatible with manipulators, incubators, etc., enabling automation.
5.Stable and reliable supply capacity and consistent product performance.
6.Supports a full range of accessories for sterile filling, inoculation, feeding, and harvesting of cell cultures.
7.0.22μm hydrophobic breathable filter membrane cover facilitates gas exchange while ensuring sterility.
8.Double-layer independent sterile packaging, SAL=10⁻⁶, pyrogen-free and non-cytotoxic.
9.The cell factory is an ideal container for static culture of adherent cells; its growth curve is consistent with that of cell culture flasks, allowing customers to quickly scale up their processes without adjusting culture methods.
10.100% leak tested before shipment.
